PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25202788-5 2014 In this connection, the efficacy of acetylcholinesterase inhibitors: galantamine (reminil),neuromidin, rivastigmine in the treatment of PD patients with dementia is discussed. amiridine 91-101 acetylcholinesterase (Cartwright blood group) Homo sapiens 36-56 9062656-2 1997 AChE inhibitors, including physostigmine, E-2020, amiridin, tetrahydroaminoacridine (THA) and Nicergoline had a poor effect on AChE present in the senile plaque-rich fraction isolated from Alzheimer brain than that either in the soluble fraction of Alzheimer brain or in the control brain. amiridine 50-58 acetylcholinesterase (Cartwright blood group) Homo sapiens 0-4 11508499-5 2001 There was a statistically significant relationship between ACE activity and the levels of primary oxidation products in the RBC of patients with AD before and after treatment with amiridine and gliatiline. amiridine 180-189 acetylcholinesterase (Cartwright blood group) Homo sapiens 59-62 9228650-2 1997 NIK-247, tacrine and E-2020 all strongly inhibited acetylcholinesterase (AChE) in human red blood cells (IC50s = 1.0 x 10(-6), 2.9 x 10(-7) and 3.7 x 10(-8) M, respectively). amiridine 0-7 acetylcholinesterase (Cartwright blood group) Homo sapiens 51-71 9228650-2 1997 NIK-247, tacrine and E-2020 all strongly inhibited acetylcholinesterase (AChE) in human red blood cells (IC50s = 1.0 x 10(-6), 2.9 x 10(-7) and 3.7 x 10(-8) M, respectively). amiridine 0-7 acetylcholinesterase (Cartwright blood group) Homo sapiens 73-77 9228650-5 1997 Moreover, the inhibitory effect of NIK-247 on AChE was reversible. amiridine 35-42 acetylcholinesterase (Cartwright blood group) Homo sapiens 46-50 11256231-4 2000 The order of inhibitory potency (IC50) towards AChE activity under optimal assay conditions for each ChE inhibitor was: physostigmine (0.67 nM) > rivastigmine (4.3 nM) > donepezil (6.7 nM) > TAK-147 (12 nM) > tacrine (77 nM) > ipidacrine (270 nM). amiridine 227-237 acetylcholinesterase (Cartwright blood group) Homo sapiens 47-51 10900685-5 2000 A significant correlation was found between AChE activity and the level of the primary products of oxidation in blood erythrocytes of AD patients before and after therapy with amiridine and gliatiline. amiridine 176-185 acetylcholinesterase (Cartwright blood group) Homo sapiens 44-48 33728848-1 2021 OBJECTIVE: To evaluate the efficacy of the AChE inhibitor ipidacrine when added to traditional therapy in outpatients with tunnel syndromes (TS) based on clinical, neurophysiological and psycho-emotional indicators. amiridine 58-68 acetylcholinesterase (Cartwright blood group) Homo sapiens 43-47 7536306-5 1994 The acetylcholinesterase inhibitor, physostigmine, exerts a similar modulatory influence on the ACh current and on its extinction, and also prevents the manifestation of the effects of amiridin and tacrine. amiridine 185-193 acetylcholinesterase (Cartwright blood group) Homo sapiens 4-24 35548968-1 2022 AIM: To evaluate the efficacy of combination of alpha-lipoic acid and acetylcholinesterase inhibitor (ipidacrine hydrochloride) to prevent the development and improve the course of paclitaxel-induced peripheral neuropathy (PIPN) in patients with breast cancer according to the Total Neuropathy Score. amiridine 102-126 acetylcholinesterase (Cartwright blood group) Homo sapiens 70-90 35548968-7 2022 RESULTS: The use of alpha-lipoic acid in combination with an acetylcholinesterase inhibitor (ipidacrine hydrochloride) significantly reduces the symptoms and severity of PIPN. amiridine 93-117 acetylcholinesterase (Cartwright blood group) Homo sapiens 61-81